gptkbp:instanceOf
|
gptkb:disease
|
gptkbp:affects
|
gptkb:skin
animals
humans
|
gptkbp:alsoKnownAs
|
gptkb:Aleppo_boil
gptkb:oriental_sore
Delhi boil
|
gptkbp:alternativeName
|
cutaneous_leishmaniasis
|
gptkbp:causedBy
|
gptkb:Leishmania_parasite
|
gptkbp:complication
|
death
disfigurement
secondary infections
secondary bacterial infection
|
gptkbp:diagnosedBy
|
PCR
microscopy
serology
|
gptkbp:firstDescribed
|
19th century
|
gptkbp:hasVaccine
|
no licensed human vaccine
|
gptkbp:ICD-10_code
|
gptkb:B55
B55.1
|
gptkbp:incubationPeriod
|
weeks to months
|
gptkbp:mortalityRate
|
high in untreated visceral leishmaniasis
|
gptkbp:namedAfter
|
gptkb:William_Boog_Leishman
|
gptkbp:prevalence
|
gptkb:Africa
gptkb:Asia
gptkb:Central_America
gptkb:Middle_East
gptkb:South_America
subtropical regions
tropical regions
southern Europe
|
gptkbp:prevention
|
personal protective equipment
insecticide-treated nets
vector control
|
gptkbp:publicHealthConcern
|
yes
|
gptkbp:relatedTo
|
gptkb:Trypanosomiasis
|
gptkbp:reservoirName
|
gptkb:dog
rodents
wild animals
|
gptkbp:symptom
|
fever
skin ulcers
enlarged liver
enlarged spleen
skin sores
weight loss
scarring
skin lesions
|
gptkbp:transmittedBy
|
sandfly
|
gptkbp:treatment
|
gptkb:amphotericin_B
gptkb:miltefosine
gptkb:paromomycin
antimonial drugs
|
gptkbp:type
|
gptkb:mucocutaneous_leishmaniasis
gptkb:visceral_leishmaniasis
leishmaniasis
|
gptkbp:vectorFor
|
gptkb:Phlebotomine_sandflies
|
gptkbp:WHOpriority
|
neglected tropical disease
|
gptkbp:zoonotic
|
true
|
gptkbp:bfsParent
|
gptkb:Leishmaniasis
|
gptkbp:bfsLayer
|
5
|